MAGICPREP
LIVE

Serial Number

90979879

Owner

TECAN GENOMICS, INC.

Attorney

Rachel A. Nicholas

First Use Date

Apr 28, 2022

Filing Date

Apr 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MAGICPREP Trademark

Serial Number: 90979879 • Registration: 7537929

MAGICPREP is a trademark filed by TECAN GENOMICS, INC. on April 23, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

TECAN GENOMICS, INC. (24 trademarks)

REDWOOD, CA 94063

Entity Type: 03

Trademark Details

Filing Date

April 23, 2021

Registration Date

October 15, 2024

First Use Anywhere

April 28, 2022

First Use in Commerce

April 28, 2022

Published for Opposition

June 21, 2022

Goods & Services

Scientific apparatus and instruments, namely, devices for pipetting for transferring liquids, reagent dispensing in the nature of machines for dispensing pre-determined dosages of reagents and laboratory apparatus for purification of nucleic acids; Scientific apparatus and instruments, namely, sampling devices for taking liquid samples in the nature of pipetting apparatus for DNA and RNA testing for scientific purposes; Scientific apparatus and instruments, namely, devices for performing polymerase chain reactions (PCR) testing for DNA and RNA for scientific purposes, all the aforementioned products for laboratory use and not for medical purposes; Reagent cartridges for holding biochemical reagents for scientific or research purposes, for use in connection with aforementioned apparatus, instruments, and devices; Recorded and downloadable software for the automation of workflows related to genomic research and genome analysis; Recorded and downloadable software for the automation of workflows related to sequencing of nucleic acids

Biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use related to nucleic acid sequencing; biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, in particular for use in clinical medical or veterinary nucleic acid-based diagnostics

Biochemical reagents for scientific or research purposes, in particular for use related to nucleic acid sequencing; Biochemical reagents for scientific or research purposes, in particular for use in genomic research

Analytical apparatus and instruments for clinical-diagnostic use and veterinary diagnostic use, namely, dispensing apparatus, sampling devices for taking liquid samples, and devices for performing polymerase chain reactions (PCR) for DNA and RNA testing for medical purposes; all the aforementioned products for clinical diagnostical and veterinary diagnostical purposes; Reagent cartridges for holding biochemical reagents for clinical medical diagnostic use and use in veterinary medicine, for use in connection with aforementioned apparatus, instruments, and devices

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 30, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 30, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 30, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 30, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 15, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 15, 2024 R.PR
EXPARTE APPEAL TERMINATED
Sep 9, 2024 EXPT
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 9, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 9, 2024 CNPR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 23, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Aug 23, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 23, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 23, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 21, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 21, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 28, 2024 GNFN
FINAL REFUSAL E-MAILED
Feb 28, 2024 GNFR
SU - FINAL REFUSAL - WRITTEN
Feb 28, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 26, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 26, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
May 25, 2023 SUPC
DIVISIONAL PROCESSING COMPLETE
May 25, 2023 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 25, 2023 AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 13, 2023 AITU
USE AMENDMENT FILED
Feb 15, 2023 IUAF
DIVISIONAL REQUEST RECEIVED
Feb 15, 2023 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Feb 15, 2023 ERTD
TEAS STATEMENT OF USE RECEIVED
Feb 15, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 16, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 21, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jun 21, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 15, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
May 15, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 19, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 19, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 19, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2021 NWOS
NEW APPLICATION ENTERED
Apr 27, 2021 NWAP